HMH compared with AKTS: revenue, margins and what each company keeps, and the suppliers and customers both name

HMHHMH Holding Inc

Mkt capRevenueRevenue

AKTSAktis Oncology, Inc.

Mkt capRevenueRevenue

Compare

HMHHMH Holding Inc

AKTSAktis Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

HMH1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.35%—

AKTS3 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.0%▲+4.79%×0.28

May 12 '26—▲+7.99%—

= impliedHMH realized, solidAKTS realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Q1 FY26—▲+8.16%—

HMHHMH Holding Inc

18.79▲+0.63%· post 18.79

Mkt cap—Revenue$171MQ2 FY26

AKTSAktis Oncology, Inc.

15.96▼−5.31%· post 15.96

ClosedOct 30 '26

Mkt cap$880.9MRevenue$3MQ2 FY26

Compare

ClosedOct 30 '26

HMHHMH Holding Inc

AKTSAktis Oncology, Inc.

18.79▲+0.63%post 18.79

Price

15.96▼−5.31%post 15.96

—

Mkt cap

$880.9M

Q2 FY26$171M

Revenue

$3MQ2 FY26

HMH18.79▲+0.63%vsAKTS15.96▼−5.31%ClosedOct 30 '26